B-cell clones as early markers for chronic lymphocytic leukemia.
paper
Cited
Public
- Authors
- Landgren, Ola; Albitar, Maher; Ma, Wanlong; Abbasi, Fatima; Hayes, Richard B; Ghia, Paolo; Marti, Gerald E; Caporaso, Neil E
- Year
- 2009
- Journal
- The New England journal of medicine
- PMID
- 19213679
- DOI
- 10.1056/NEJMoa0806122
- PMCID
- PMC7015348
BACKGROUND: Otherwise healthy persons with a small number of B-cell clones circulating in the peripheral blood have been designated as having monoclonal B-cell lymphocytosis (MBL). Hospital-based series indicate an excess risk of progression from MBL to chronic lymphocytic leukemia (CLL). In this prospective cohort study, we tested the hypothesis that CLL is always preceded by MBL. METHODS: Among 77,469 healthy adults who were enrolled in the nationwide, population-based Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial, we identified 45 subjects in whom CLL was subsequently diagnosed (up to 6.4 years later) through the collection of a peripheral-blood sample. Using six-color flow cytometry (with antibodies CD45, CD19, CD5, CD10, kappa, and lambda) and immunoglobulin heavy-chain gene rearrangement by reverse-transcriptase-polymerase-chain-reaction assay, we determined the association between MBL and subsequent CLL and characterized the immunoglobulin gene repertoire of the prediagnostic B-cell clones. RESULTS: On the basis of either flow-cytometric or molecular analysis, 44 of 45 patients with CLL (98%; 95% confidence interval [CI], 88 to 100) had a prediagnostic B-cell clone; in 41 patients (91%; 95% CI, 79 to 98), the presence of the B-cell clone was confirmed by both methods. The presence of immunoglobulin heavy-chain variable (IGHV) genes was determined in 35 of 45 prediagnostic clones (78%). Of these clones, 16 (46%) were IGHV3 subgroup genes (including 6 [17%] IGHV3-23 genes) and 9 (26%) were IGHV4 subgroup genes (including 4 [11%] IGHV4-34 genes). Furthermore, 27 of 35 of the IGHV sequences (77%) had mutations, with similar distributions after stratification either below or above the median time between the collection of the prediagnostic blood sample and the subsequent CLL diagnosis. CONCLUSIONS: In peripheral blood obtained up to 77 months before a CLL diagnosis, prediagnostic B-cell clones were present in 44 of 45 patients with CLL.
Six-Color Flow-Cytometric Analysis, Showing Representative Kappa Light-Chain Restriction in Prediagnostic Blood Samples from the Patients.Panel A shows a bivariant plot of CD45 against side scatter, showing the isolation of lymphocytes incubated with anti-CD45 allophycocyanin H7 (APC-H7). Panel B shows a plot of CD19 against CD5. The monoclonal B-cell lymphocytosis (MBL) clone (red), positive for anti-CD19 peridininβchlorophyllβprotein cyanine 5.5 (PerCP-Cy5.5), shows coexpression of CD19 and CD5. The green population represents the remaining CD5-positive T cells, and the blue population represents the remaining polyclonal B cells. Panel C shows that the red population, positive for anti-kappa allophycocyanin (APC), has a kappa light-chain restriction. Panel D shows that the remaining B cells (blue) are polyclonal. FITC denotes fluorescein isothiocyanate, and PE phycoerythrin.
IGHV Rearrangements, as Detected on RT-PCR Assay, Showing a Monoclonal Band in a Prediagnostic Blood Sample from a Patient with Subsequent CLL.
1β20 of 24
Next β
No entities extracted from this document yet.
No uploaded files.
Not in any collection.
| Citation | PMID | DOI | Status |
|---|---|---|---|
| CarboneA, GloghiniA, GaidanoG, Expression status of BCL-6 and syndecan-1 identifies distinct histogenetic subtypes of Hodgkinβs disease. Blood 1998; 92:2220β8.9746758 | β | β | β |
| DamleRN, WasilT, FaisF, Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. Blood 1999;94: 1840β7.10477712 | β | β | β |
| de TuteR, YuilleM, CatovskyD, HoulstonRS, HillmenP, RawstronAC. Monoclonal B-cell lymphocytosis (MBL) in CLL families: substantial increase in relative risk for young adults. Leukemia 2006;20:728β9.1643714110.1038/sj.leu.2404116 | β | β | β |
| French Cooperative Group on Chronic Lymphocytic Leukaemia. Natural history of stage A chronic lymphocytic leukaemia untreated patients. Br J Haematol 1990; 76:45β57.10.1111/j.1365-2141.1990.tb07835.x2223648 | β | β | β |
| GarnierJL, LebranchuY, LefrancoisN, Hodgkinβs disease after renal transplantation. Transplant Proc 1995;27:1785.7725504 | β | β | β |
| GhiaP, PratoG, ScielzoC, Monoclonal CD5+ and CD5- B-lymphocyte expansions are frequent in the peripheral blood of the elderly. Blood 2004;103:2337β42.1463080810.1182/blood-2003-09-3277 | β | β | β |
| GhiaP, StamatopoulosK, BelessiC, ERIC recommendations on IGHV gene mutational status analysis in chronic lymphocytic leukemia. Leukemia 2007;21:1β3.1716752610.1038/sj.leu.2404457 | β | β | β |
| GiudicelliV, ChaumeD, LefrancMP. IMGT/V-QUEST, an integrated software program for immunoglobulin and T cell receptor V-J and V-D-J rearrangement analysis. Nucleic Acids Res 2004;32:W435βW440.1521542510.1093/nar/gkh412PMC441550 | β | β | β |
| GoldinLR, BjorkholmM, KristinssonSY, TuressonI, LandgrenO. Elevated risk of chronic lymphocytic leukemia (CLL) and other indolent non-Hodgkin lymphomas among relatives of CLL patients. Haematologica 2009 (in press).10.3324/haematol.2008.003632PMC267567619286886 | β | β | β |
| HamblinTJ, DavisZ, GardinerA, OscierDG, StevensonFK. Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia. Blood 1999;94:1848β54.10477713 | β | β | β |
| HanT, OzerH, GaviganM, Benign monoclonal B cell lymphocytosis β a benign variant of CLL: clinical, immunologic, phenotypic, and cytogenetic studies in 20 patients. Blood 1984;64:244β52.6610446 | β | β | β |
| HayesRB, SigurdsonA, MooreL, Methods for etiologic and early marker investigations in the PLCO trial. Mutat Res 2005;592:147β54.1605416710.1016/j.mrfmmm.2005.06.013 | β | β | β |
| HayesRB, SmithCO, HuangWY, ReadY, KoppWC. Whole blood cryopreservation in epidemiological studies. Cancer Epidemiol Biomarkers Prev 2002;11:1496β8.12433734 | β | β | β |
| JaffeES, HarrisNL, SteinH, VardimanJW, eds. World Health Organization classification of tumours Pathology and genetics of tumours of haematopoietic and lymphoid tissues. Lyon: IARC Press, 2001. | β | β | β |
| JamroziakK, BalcerczakE, SmolewskiP, MDR1 (ABCB1) gene polymorphism C3435T is associated with P-glycoprotein activity in B-cell chronic lymphocytic leukemia. Pharmacol Rep 2006;58:720β8.17085864 | β | β | β |
| KippsTJ. The B-cell receptor and ZAP-70 in chronic lymphocytic leukemia. Best Pract Res Clin Haematol 2007;20:415β24.1770783010.1016/j.beha.2007.04.001 | β | β | β |
| LandgrenO, EngelsEA, CaporasoNE, Patterns of autoimmunity and subsequent chronic lymphocytic leukemia in Nordic countries. Blood 2006;108:292β6.1652788710.1182/blood-2005-11-4620PMC1895837 | β | β | β |
| LandgrenO, GridleyG, CheckD, CaporasoNE, Morris BrownL. Acquired immune-related and inflammatory conditions and subsequent chronic lymphocytic leukaemia. Br J Haematol 2007;139:791β8.1794195010.1111/j.1365-2141.2007.06859.x | β | β | β |
| LandgrenO, KyleRA. Multiple myeloma, chronic lymphocytic leukaemia and associated precursor diseases. Br J Haematol 2007;139:717β23.1802108610.1111/j.1365-2141.2007.06866.x | β | β | β |
| LandgrenO, RapkinJS, CaporasoNE, Respiratory tract infections and subsequent risk of chronic lymphocytic leukemia. Blood 2007;109:2198β201.1708231710.1182/blood-2006-08-044008PMC1801057 | β | β | β |
| LinetMS, Schubauer-BeriganMK, WeisenburgerDD, Chronic lymphocytic leukaemia: an overview of aetiology in light of recent developments in classification and pathogenesis. Br J Haematol 2007;139:672β86.1802108110.1111/j.1365-2141.2007.06847.x | β | β | β |
| MartiGE, RawstronAC, GhiaP, Diagnostic criteria for monoclonal B-cell lymphocytosis. Br J Haematol 2005;130: 325β32.1604268210.1111/j.1365-2141.2005.05550.x | β | β | β |
| MessmerBT, AlbesianoE, MessmerD, ChiorazziN. The pattern and distribution of immunoglobulin VH gene mutations in chronic lymphocytic leukemia B cells are consistent with the canonical somatic hypermutation process. Blood 2004;103:3490β5.1469523210.1182/blood-2003-10-3407 | β | β | β |
| MontserratE, VinolasN, ReverterJC, RozmanC. Natural history of chronic lymphocytic leukemia: on the progression and progression and prognosis of early clinical stages. Nouv Rev Fr Hematol 1988; 30:359β61.3222145 | β | β | β |
| ProrokPC, AndrioleGL, BresalierRS, Design of the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. Control Clin Trials 2000;21: Suppl:273Sβ309S.1118968410.1016/s0197-2456(00)00098-2 | β | β | β |
| RawstronAC, BennettF, HillmenP. The biological and clinical relationship between CD5+23+ monoclonal B-cell lymphocytosis and chronic lymphocytic leukaemia. Br J Haematol 2007;139:724β9.1802108710.1111/j.1365-2141.2007.06863.x | β | β | β |
| RawstronAC, BennettFL, OβConnorSJ, Monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia. N Engl J Med 2008;359:575β83.1868763810.1056/NEJMoa075290 | β | β | β |
| RawstronAC, GreenMJ, KuzmickiA, Monoclonal B lymphocytes with the characteristics of βindolentβ chronic lymphocytic leukemia are present in 3.5% of adults with normal blood counts. Blood 2002;100:635β9.1209135810.1182/blood.v100.2.635 | β | β | β |
| RawstronAC. Prevalence and characteristics of monoclonal B-cell lymphocytosis (MBL) in healthy individuals and the relationship with clinical disease. J Biol Regul Homeost Agents 2004;18:155β60.15471220 | β | β | β |
| RiesLAG, MelbertD, KrapchoM, , eds. SEER cancer statistics review, 1975β2005 (based on November 2007 SEER data submission). Bethesda, MD: National Cancer Institute, 2008. | β | β | β |
| RuddMF, SellickGS, WebbEL, CatovskyD, HoulstonRS. Variants in the ATM-BRCA2-CHEK2 axis predispose to chronic lymphocytic leukemia. Blood 2006; 108:638β44.1657495310.1182/blood-2005-12-5022 | β | β | β |
| ShanafeltTD, KayNE, CallTG, MBL or CLL: which classification best categorizes the clinical course of patients with an absolute lymphocyte count > or =5Γ10(9)L(β1) but a B-cell lymphocyte count <5Γ10(9)L(β1)? Leuk Res 2008;32:1458β61.1817982110.1016/j.leukres.2007.11.030PMC2587320 | β | β | β |
| StamatopoulosK, BelessiC, MorenoC, Over 20% of patients with chronic lymphocytic leukemia carry stereotyped receptors: pathogenetic implications and clinical correlations. Blood 2007;109:25970.10.1182/blood-2006-03-01294816985177 | β | β | β |
| ThorsΓ©liusM, KrΓΆberA, MurrayF, Strikingly homologous immunoglobulin gene rearrangements and poor outcome in VH3β21-using chronic lymphocytic leukemia patients independent of geographic origin and mutational status. Blood 2006;107:2889β94.1631710310.1182/blood-2005-06-2227 | β | β | β |
| TomitaY, OhsawaM, KannoH, Epstein-Barr virus in Hodgkinβs disease patients in Japan. Cancer 1996;77:186β92.863092810.1002/(SICI)1097-0142(19960101)77:1<186::AID-CNCR30>3.0.CO;2-# | β | β | β |
| VogtRF, MeredithMNK, PowellJ, Results in eleven individuals with B-CLL-like phenotypes detected in environmental health studies In: MartiGE, VogtRF, ZengerVE, eds. Proceedings of the USPHS workshop on laboratory approaches to determining the role of environmental exposures as risk factors for B-cell chronic lymphocytic leukemia and other B-cell lymphoproliferative disorders. Atlanta: Department of Health and Human Services, 1995:19β35. | β | β | β |
In this knowledge base
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| Evolution of multiple myeloma from a genomic perspective. | Maura F et al. | β | 2026 | β |
| CHIP amplifies the risk of lymphoid malignancies in individuals with monoclonal B-cell lymphocytosis (MBL). | Boddicker NJ et al. | β | 2025 | β |
| Cohort Profile: The Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. | Miller EA et al. | β | 2025 | β |
| Diagnosis and treatment of chronic lymphocytic leukemia: 2025 recommendations of the Brazilian Group of Chronic Lymphocytic Leukemia of the Brazilian Association of Hematology and Hemotherapy (ABHH). | Chiattone CS et al. | β | 2025 | β |
| Donor Cell-Derived Chronic Lymphocytic Leukemia Presenting After Allogenic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. | Czempik K et al. | β | 2025 | β |
| Insights into the pathogenesis and biology of chronic lymphocytic leukemia through analysis of its B-cell receptor. | Dampmann M et al. | β | 2025 | β |
| Machine Learning Model Predicts Abnormal Lymphocytosis Associated With Chronic Lymphocytic Leukemia. | Aoki J et al. | β | 2025 | β |
| Monoclonal B-Cell Lymphocytosis: The Silent Clone the Haematologists Should Not Neglect. | Serafin A et al. | β | 2025 | β |
| Precursor Hematologic Conditions: Diagnosis, Risk Stratification, Clinical Implications, and Management. | Liu Y et al. | β | 2025 | β |
| Autonomous B-cell receptor signaling and genetic aberrations in chronic lymphocytic leukemia-phenotype monoclonal B lymphocytosis in siblings of patients with chronic lymphocytic leukemia. | Quinten E et al. | β | 2024 | β |
| Clinical Risks for Chronic Lymphocytic Leukemia. | Brown JR | β | 2024 | β |
| Immune Dysfunction and Infection - Interaction between CLL and Treatment: A Reflection on Current Treatment Paradigms and Unmet Needs. | Gargiulo E et al. | β | 2024 | β |
| Increased Expression of ITGB 3 in CLL Patient leukemia Cells by Exposure to Cold Physical Plasma and Plasma-treated Medium. | Golpour M et al. | β | 2024 | β |
| Mosaic chromosomal alterations (mCAs) in individuals with monoclonal B-cell lymphocytosis (MBL). | Sekar A et al. | β | 2024 | β |
| Prediction of outcomes for high-count monoclonal BΒ lymphocytosis using an epigenetic and immunogenetic signature. | Abdelbaky SB et al. | β | 2024 | β |
| Prehistory of chronic lymphocytic leukemia: clues from the B-cell receptor. | Davi F | β | 2024 | β |
| Risk of Incident Melanoma Among Individuals With Low-Count Monoclonal B-Cell Lymphocytosis. | Vallejo BA et al. | β | 2024 | β |
| The molecular map of CLL and Richter's syndrome. | Sud A et al. | β | 2024 | β |
| Tumor mutational load is prognostic for progression to therapy among high-count monoclonal B-cell lymphocytosis. | Kleinstern G et al. | β | 2024 | β |
| Utility of Targeted Sequencing Compared to FISH for Detection of Chronic Lymphocytic Leukemia Copy Number Alterations. | Wiedmeier-Nutor JE et al. | β | 2024 | β |
| An updated perspective on immunoglobulin replacement in chronic lymphocytic leukaemia in the era of targeted therapies. | Khan S et al. | β | 2023 | β |
| Association between peripheral blood cytopenia and cancer mortality: A race-specific risk factor for cancer death. | Adrianzen-Herrera DA et al. | β | 2023 | β |
| CHIPing away the progression potential of CHIP: A new reality in the making. | Xie Z et al. | β | 2023 | β |
| Circulating immune markers and risks of non-Hodgkin lymphoma subtypes: A pooled analysis. | Rhee J et al. | β | 2023 | β |
| Genetic drivers in the natural history of chronic lymphocytic leukemia development as early as 16 years before diagnosis. | Kolijn PM et al. | β | 2023 | β |
| Progression and transformation of chronic lymphocytic leukemia/small lymphocytic lymphoma and B-cell prolymphocytic leukemia: Report from the 2021 SH/EAHP Workshop. | Czader M et al. | β | 2023 | β |
| SOHO State of the Art Updates and Next Questions | Infections in Chronic Lymphocytic Leukemia Patients: Risks and Management. | Gargiulo E et al. | β | 2023 | β |
| The inherited genetic contribution and polygenic risk score for risk of CLL and MBL: a narrative review. | Kleinstern G et al. | β | 2023 | β |
| VIP152 is a selective CDK9 inhibitor with pre-clinical in vitro and in vivo efficacy in chronic lymphocytic leukemia. | Sher S et al. | β | 2023 | β |
| Associations of history of vaccination and hospitalization due to infection with risk of monoclonal B-cell lymphocytosis. | Boddicker NJ et al. | β | 2022 | β |
| Biallelic germline mutations in MAD1L1 induce a syndrome of aneuploidy with high tumor susceptibility. | Villarroya-Beltri C et al. | β | 2022 | β |
| Bilallelic germline mutations in<i>MAD1L1</i>induce a novel syndrome of aneuploidy with high tumor susceptibility | Villarroya-Beltri C et al. | β | 2022 | β |
| Chronic lymphocytic leukaemia clones are detectable decades before diagnosis. | Vojdeman FJ et al. | β | 2022 | β |
| High-risk subtypes of chronic lymphocytic leukemia are detectable as early as 16 years prior to diagnosis. | Kolijn PM et al. | β | 2022 | β |
| Monoclonal B-cell Lymphocytosis - a review of diagnostic criteria, biology, natural history, and clinical management. | Tang C et al. | β | 2022 | β |
| Monoclonal B-cell lymphocytosis in the bone marrow: revisiting the criteria for chronic lymphocytic leukemia/small lymphocytic lymphoma. | Ryder CB et al. | β | 2022 | β |
| Polygenic risk score and risk of monoclonal B-cell lymphocytosis in caucasians and risk of chronic lymphocytic leukemia (CLL) in African Americans. | Kleinstern G et al. | β | 2022 | β |
| Pre-diagnostic trajectories of lymphocytosis predict time to treatment and death in patients with chronic lymphocytic leukemia. | Andersen MA et al. | β | 2022 | β |
| Progression and survival of MBL: a screening study of 10β139 individuals. | Slager SL et al. | β | 2022 | β |
| A new score including CD43 and CD180: Increased diagnostic value for atypical chronic lymphocytic leukemia. | Li Y et al. | β | 2021 | β |
| Antimicrobial use before chronic lymphocytic leukemia: a retrospective cohort study. | Andersen MA et al. | β | 2021 | β |
| Chronic Lymphocytic Leukemia. | Chiorazzi N et al. | β | 2021 | β |
| Chronic lymphocytic leukemia-like monoclonal B-cell lymphocytosis exhibits an increased inflammatory signature that is reduced in early-stage chronic lymphocytic leukemia. | Blanco G et al. | β | 2021 | β |
| Designing Evolutionary-based Interception Strategies to Block the Transition from Precursor Phases to Multiple Myeloma. | Maura F et al. | β | 2021 | β |
| Familial patterns of hematologic precursors. | Landgren O et al. | β | 2021 | β |
| Forward and Reverse Genetics of B Cell Malignancies: From Insertional Mutagenesis to CRISPR-Cas. | Dawes JC et al. | β | 2021 | β |
| Immune Gene Rearrangements: Unique Signatures for Tracing Physiological Lymphocytes and Leukemic Cells. | Kotrova M et al. | β | 2021 | β |
| Natural history of monoclonal B-cell lymphocytosis among relatives in CLL families. | Slager SL et al. | β | 2021 | β |
| New developments in non-Hodgkin lymphoid malignancies. | Ganapathi KA et al. | β | 2021 | β |
| O-GlcNAcylation in Chronic Lymphocytic Leukemia and Other Blood Cancers. | Spaner DE | β | 2021 | β |
| Post-Transformation IGHV-IGHD-IGHJ Mutations in Chronic Lymphocytic Leukemia B Cells: Implications for Mutational Mechanisms and Impact on Clinical Course. | Bagnara D et al. | β | 2021 | β |
| Preneoplastic Alterations Define CLL DNA Methylome and Persist through Disease Progression and Therapy. | Kretzmer H et al. | β | 2021 | β |
| Understanding Monoclonal B Cell Lymphocytosis: An Interplay of Genetic and Microenvironmental Factors. | Galigalidou C et al. | β | 2021 | β |
| A higher frequency of monoclonal B cell lymphocytosis among Egyptian relatives of CLL patients. | Kassem S et al. | β | 2020 | β |
| BΒ Cell Lymphoma. | Meng X et al. | β | 2020 | β |
| Chronic lymphocytic leukemia: from molecular pathogenesis to novel therapeutic strategies. | Delgado J et al. | β | 2020 | β |
| Diagnosis and Treatment of Chronic Lymphocytic Leukemia: Recommendations of the French CLL Study Group (FILO). | Quinquenel A et al. | β | 2020 | β |
| High frequency of chronic lymphocytic leukemia-like low-count monoclonal B-cell lymphocytosis in Japanese descendants living in Brazil. | de Faria-Moss M et al. | β | 2020 | β |
| High-throughput analysis of the T cell receptor gene repertoire in low-count monoclonal B cell lymphocytosis reveals a distinct profile from chronic lymphocytic leukemia. | Agathangelidis A et al. | β | 2020 | β |
| Novel Therapies in Chronic Lymphocytic Leukemia: A Rapidly Changing Landscape. | Iovino L et al. | β | 2020 | β |
| Pathogenesis of chronic lymphocytic leukemia and the development of novel therapeutic strategies. | Kikushige Y | β | 2020 | β |
| Pathophysiology of chronic lymphocytic leukemia and human B1 cell development. | Kikushige Y | β | 2020 | β |
| Plasma proteomic profiling suggests an association between antigen driven clonal B cell expansion and ME/CFS. | Milivojevic M et al. | β | 2020 | β |
| Prevalence and Immunophenotypic Characteristics of Monoclonal B-Cell Lymphocytosis in Healthy Korean Individuals With Lymphocytosis. | Yoo IY et al. | β | 2020 | β |
| Recent advances in chronic lymphocytic leukemia therapy. | Uhm J | β | 2020 | β |
| Serum levels of hsa-miR-16-5p, hsa-miR-29a-3p, hsa-miR-150-5p, hsa-miR-155-5p and hsa-miR-223-3p and subsequent risk of chronic lymphocytic leukemia in the EPIC study. | Casabonne D et al. | β | 2020 | β |
| Chronic lymphocytic leukaemia: from genetics to treatment. | Bosch F et al. | β | 2019 | β |
| Clinical presentation and hematological profile among young and old chronic lymphocytic leukemia patients in Sudan. | Basabaeen AA et al. | β | 2019 | β |
| Elevated IgM and abnormal free light chain ratio are increased in relatives from high-risk chronic lymphocytic leukemia pedigrees. | Glenn MJ et al. | β | 2019 | β |
| Entinostat combined with Fludarabine synergistically enhances the induction of apoptosis in TP53 mutated CLL cells via the HDAC1/HO-1 pathway. | Zhou Z et al. | β | 2019 | β |
| Monoclonal B-cell lymphocytosis. | Maitre E et al. | β | 2019 | β |
| Presenting features and treatment outcomes of chronic lymphocytic leukaemia in a resource poor Southern Nigeria. | Madu AJ et al. | β | 2019 | β |
| [Revised version of the 4th edition of the WHO classification of malignant lymphomas : What is new?] | Ott G et al. | β | 2019 | β |
| Age-related clonal hematopoiesis and monoclonal B-cell lymphocytosis/chronic lymphocytic leukemia: a new association? | Condoluci A et al. | β | 2018 | β |
| A Practical Cryopreservation and Staining Protocol for Immunophenotyping in Population Studies. | Barcelo H et al. | β | 2018 | β |
| Association of polygenic risk score with the risk of chronic lymphocytic leukemia and monoclonal B-cell lymphocytosis. | Kleinstern G et al. | β | 2018 | β |
| Chronic Lymphocytic Leukemia B-Cell Normal Cellular Counterpart: Clues From a Functional Perspective. | Darwiche W et al. | β | 2018 | β |
| From Mice to Men: How B Cell Immunology Helped the Understanding of Leukemia Development. | Ghia P | β | 2018 | β |
| Highly similar genomic landscapes in monoclonal B-cell lymphocytosis and ultra-stable chronic lymphocytic leukemia with low frequency of driver mutations. | Agathangelidis A et al. | β | 2018 | β |
| Insights into clonal haematopoiesis from 8,342 mosaic chromosomal alterations. | Loh PR et al. | β | 2018 | β |
| Low-count monoclonal B-cell lymphocytosis persists after seven years of follow up and is associated with a poorer outcome. | Criado I et al. | β | 2018 | β |
| Lymphoma-like monoclonal B cell lymphocytosis in a patient population: biology, natural evolution, and differences from CLL-like clones. | Vander Meeren S et al. | β | 2018 | β |
| Monoclonal B-cell lymphocytosis: Does the elderly patient need a specialistic approach? | Angelillo P et al. | β | 2018 | β |
| Monoclonal B-cell lymphocytosis in blood donors in Turkey. | YaΔcΔ± M et al. | β | 2018 | β |
| NOTCH1 Aberrations in Chronic Lymphocytic Leukemia. | Rosati E et al. | β | 2018 | β |
| Outcomes of a large cohort of individuals with clinically ascertained high-count monoclonal B-cell lymphocytosis. | Parikh SA et al. | β | 2018 | β |
| Residual normal B-cell profiles in monoclonal B-cell lymphocytosis versus chronic lymphocytic leukemia. | Criado I et al. | β | 2018 | β |
| Somatic CLL mutations occur at multiple distinct hematopoietic maturation stages: documentation and cautionary note regarding cell fraction purity. | Marsilio S et al. | β | 2018 | β |
| 2016 WHO Classification update-What's new in lymphoid neoplasms. | Hsi ED | β | 2017 | β |
| Advances in the understanding of IgM monoclonal gammopathy of undetermined significance. | Paludo J et al. | β | 2017 | β |
| Chronic lymphocytic leukemia and small lymphocytic lymphoma: two faces of the same disease. | Tees MT et al. | β | 2017 | β |
| Clinical and Laboratory Features of CD5-Negative Chronic Lymphocytic Leukemia. | Demir C et al. | β | 2017 | β |
| Clinical Impact of the 2016 Update to the WHO Lymphoma Classification. | Lynch RC et al. | β | 2017 | β |
| Clonal evolution is a prognostic factor for the clinical progression of monoclonal B-cell lymphocytosis. | Kostopoulos IV et al. | β | 2017 | β |
| Coevolution of Leukemia and Host Immune Cells in Chronic Lymphocytic Leukemia. | Purroy N et al. | β | 2017 | β |
| Comparison of microRNA expression in high-count monoclonal B-cell lymphocytosis and Binet A chronic lymphocytic leukemia. | Furtado FM et al. | β | 2017 | β |
| Early stages in the ontogeny of small B-cell lymphomas: genetics and microenvironment. | Ghia P et al. | β | 2017 | β |
| Evolving DNA methylation and gene expression markers of B-cell chronic lymphocytic leukemia are present in pre-diagnostic blood samples more than 10Β years prior to diagnosis. | Georgiadis P et al. | β | 2017 | β |
| Lymphoma classification update: B-cell non-Hodgkin lymphomas. | Jiang M et al. | β | 2017 | β |
| Monoclonal B-cell lymphocytosis in a hospital-based UK population and a rural Ugandan population: a cross-sectional study. | Rawstron AC et al. | β | 2017 | β |
| Pathways towards indolent B-cell lymphoma - Etiology and therapeutic strategies. | van den Brand M et al. | β | 2017 | β |
| Prevalence and relative proportions of CLL and non-CLL monoclonal B-cell lymphocytosis phenotypes in the Middle Eastern population. | Aljurf M et al. | β | 2017 | β |
| Alterations in the mir-15a/16-1 Loci Impairs Its Processing and Augments B-1 Expansion in De Novo Mouse Model of Chronic Lymphocytic Leukemia (CLL). | Kasar S et al. | β | 2016 | β |
| Challenges in the Role of Gammaglobulin Replacement Therapy and Vaccination Strategies for Hematological Malignancy. | SΓ‘nchez-RamΓ³n S et al. | β | 2016 | β |
| Detection of non-CLL-like monoclonal B cell lymphocytosis increases dramatically in the very elderly, while detection of CLL-like populations varies by race: findings in a multiethnic population-based cohort of elderly women. | Edlefsen KL et al. | β | 2016 | β |
| Diagnosis and treatment of chronic lymphocytic leukemia: recommendations from the Brazilian Group of Chronic Lymphocytic Leukemia. | Rodrigues CA et al. | β | 2016 | β |
| Frequency of monoclonal B-cell lymphocytosis in relatives of patients with chronic lymphocytic leukemia. | Villegas Gracia R et al. | β | 2016 | β |
| Issues in diagnosis of small B cell lymphoid neoplasms involving the bone marrow and peripheral blood. Report on the Bone Marrow Workshop of the XVIIth meeting of the European Association for Haematopathology and the Society for Hematopathology. | Porwit A et al. | β | 2016 | β |
| Monoclonal B-cell Lymphocytosis in a Patient with Wegener Granulomatosis: A Case Report and Update on 2016 World Health Organization Classification. | Yang CL et al. | β | 2016 | β |
| Monoclonal B-cell lymphocytosis in the population of Slovenian region of Lower Carniola. | Bajuk P et al. | β | 2016 | β |
| Next-generation IgVH sequencing CLL-like monoclonal B-cell lymphocytosis reveals frequent oligoclonality and ongoing hypermutation. | Klinger M et al. | β | 2016 | β |
| Prognostic indices in chronic lymphocytic leukaemia: where do we stand how do we proceed? | Baliakas P et al. | β | 2016 | β |
| The 2016 revision of the World Health Organization classification of lymphoid neoplasms. | Swerdlow SH et al. | β | 2016 | β |
| The molecular pathogenesis of chronic lymphocytic leukaemia. | Fabbri G et al. | β | 2016 | β |
| A retrospective study of patients with follicular lymphoma (FL): identification of in situ FL or FL-like B cells of uncertain significance in lymph nodes resected at the time of previous surgery for carcinomas. | Morita K et al. | β | 2015 | β |
| A seven-gene expression panel distinguishing clonal expansions of pre-leukemic and chronic lymphocytic leukemia B cells from normal B lymphocytes. | McCarthy BA et al. | β | 2015 | β |
| Chronic lymphocytic leukemia cells express CD38 in response to Th1 cell-derived IFN-Ξ³ by a T-bet-dependent mechanism. | BΓΌrgler S et al. | β | 2015 | β |
| Clinicopathological and phenotypic features of chronic NK cell lymphocytosis identified among patients with asymptomatic lymphocytosis. | Cao F et al. | β | 2015 | β |
| Deciphering the molecular landscape in chronic lymphocytic leukemia: time frame of disease evolution. | Sutton LA et al. | β | 2015 | β |
| Genomic and epigenomic heterogeneity in chronic lymphocytic leukemia. | GuiΓ¨ze R et al. | β | 2015 | β |
| Hospital population screening reveals overrepresentation of CD5(-) monoclonal B-cell lymphocytosis and monoclonal gammopathy of undetermined significance of IgM type. | Voigtlaender M et al. | β | 2015 | β |
| Immunophenotypic analysis reveals heterogeneity and common biologic aspects in monoclonal B-cell lymphocytosis. | Kostopoulos IV et al. | β | 2015 | β |
| Lack of glucocorticoid-induced leucine zipper (GILZ) deregulates B-cell survival and results in B-cell lymphocytosis in mice. | Bruscoli S et al. | β | 2015 | β |
| Lag times between lymphoproliferative disorder and clinical diagnosis of chronic lymphocytic leukemia: a prospective analysis using plasma soluble CD23. | Kaaks R et al. | β | 2015 | β |
| Mitochondrial DNA copy number and chronic lymphocytic leukemia/small lymphocytic lymphoma risk in two prospective studies. | Kim C et al. | β | 2015 | β |
| Monoclonal B-cell lymphocytosis. | Biasoli I et al. | β | 2015 | β |
| Monoclonal B-cell lymphocytosis and early-stage chronic lymphocytic leukemia: diagnosis, natural history, and risk stratification. | Strati P et al. | β | 2015 | β |
| Nature and nurture: a case of transcending haematological pre-malignancies in a pair of monozygotic twins adding possible clues on the pathogenesis of B-cell proliferations. | Hansen MC et al. | β | 2015 | β |
| No evidence of transmission of chronic lymphocytic leukemia through blood transfusion. | Hjalgrim H et al. | β | 2015 | β |
| Premalignant cell dynamics in indolent B-cell malignancies. | Milpied P et al. | β | 2015 | β |
| Pre-malignant lymphoid cells arise from hematopoietic stem/progenitor cells in chronic lymphocytic leukemia. | Kikushige Y et al. | β | 2015 | β |
| Prevalence of monoclonal B lymphocytosis in first-degree relatives of chronic lymphocytic leukemia patients in Turkey. | Demirci T et al. | β | 2015 | β |
| Primary diffuse large B-cell lymphoma associated with clonally-related monoclonal B lymphocytosis indicates a common precursor cell. | Malecka A et al. | β | 2015 | β |
| Single-Cell Analysis and Next-Generation Immuno-Sequencing Show That Multiple Clones Persist in Patients with Chronic Lymphocytic Leukemia. | Kriangkum J et al. | β | 2015 | β |
| The PLCO Biorepository: Creating, Maintaining, and Administering a Unique Biospecimen Resource. | Carrick DM et al. | β | 2015 | β |
| Acquired chromosomal anomalies in chronic lymphocytic leukemia patients compared with more than 50,000 quasi-normal participants. | Laurie CC et al. | β | 2014 | β |
| Chronic lymphocytic leukaemia: could immunological tolerance mechanisms be the origin of lymphoid neoplasms? | GarcΓa-MuΓ±oz R et al. | β | 2014 | β |
| Cytokines in serum in relation to future non-Hodgkin lymphoma risk: evidence for associations by histologic subtype. | Edlefsen KL et al. | β | 2014 | β |
| Distinction between asymptomatic monoclonal B-cell lymphocytosis with cyclin D1 overexpression and mantle cell lymphoma: from molecular profiling to flow cytometry. | Espinet B et al. | β | 2014 | β |
| Hematopoietic stem cell aging and chronic lymphocytic leukemia pathogenesis. | Kikushige Y et al. | β | 2014 | β |
| Immune defects in the risk of infection and response to vaccination in monoclonal gammopathy of undetermined significance and multiple myeloma. | Tete SM et al. | β | 2014 | β |
| Monoclonal B-cell lymphocytosis. | D'Arena G et al. | β | 2014 | β |
| Monoclonal B cell lymphocytosis and "in situ" lymphoma. | Karube K et al. | β | 2014 | β |
| Monoclonal B-cell lymphocytosis in donors. | Stetler-Stevenson M | β | 2014 | β |
| Monoclonal B-cell lymphocytosis in healthy blood donors: an unexpectedly common finding. | Shim YK et al. | β | 2014 | β |
| Monoclonal B-cell lymphocytosis is characterized by mutations in CLL putative driver genes and clonal heterogeneity many years before disease progression. | Ojha J et al. | β | 2014 | β |
| Mouse models in the study of chronic lymphocytic leukemia pathogenesis and therapy. | Simonetti G et al. | β | 2014 | β |
| Multiple productive immunoglobulin heavy chain gene rearrangements in chronic lymphocytic leukemia are mostly derived from independent clones. | Plevova K et al. | β | 2014 | β |
| Persistence and selection of an expanded B-cell clone in the setting of rituximab therapy for SjΓΆgren's syndrome. | Hershberg U et al. | β | 2014 | β |
| Prediagnostic transcriptomic markers of Chronic lymphocytic leukemia reveal perturbations 10 years before diagnosis. | Chadeau-Hyam M et al. | β | 2014 | β |
| Shifting ecologies of malignant and nonmalignant cells following BRAF inhibition. | Wu CJ | β | 2014 | β |
| t(14;18) Translocation: A predictive blood biomarker for follicular lymphoma. | Roulland S et al. | β | 2014 | β |
| Bone marrow histology in monoclonal B-cell lymphocytosis shows various B-cell infiltration patterns. | Randen U et al. | β | 2013 | β |
| Chronic lymphocytic leukemia: a tale of one or two signals? | Chiorazzi N et al. | β | 2013 | β |
| Clonal evolution, genomic drivers, and effects of therapy in chronic lymphocytic leukemia. | Ouillette P et al. | β | 2013 | β |
| Combined patterns of IGHV repertoire and cytogenetic/molecular alterations in monoclonal B lymphocytosis versus chronic lymphocytic leukemia. | Henriques A et al. | β | 2013 | β |
| Early neoplastic lymphoid lesions. | Carvajal-Cuenca A et al. | β | 2013 | β |
| Follicular lymphoma-like B cells of uncertain significance (in situ follicular lymphoma) may infrequently progress, but precedes follicular lymphoma, is associated with other overt lymphomas and mimics follicular lymphoma in flow cytometric studies. | Pillai RK et al. | β | 2013 | β |
| Genomic stratification for the treatment of lymphomas. | Dave SS | β | 2013 | β |
| Germline allele-specific expression of DAPK1 in chronic lymphocytic leukemia. | Wei QX et al. | β | 2013 | β |
| Immunogenetics shows that not all MBL are equal: the larger the clone, the more similar to CLL. | Vardi A et al. | β | 2013 | β |
| Increased cancer burden among pesticide applicators and others due to pesticide exposure. | Alavanja MC et al. | β | 2013 | β |
| Inherited susceptibility to chronic lymphocytic leukemia: evidence and prospects for the future. | Brown JR | β | 2013 | β |
| Investigation of epstein-barr virus as a potential cause of B-cell non-Hodgkin lymphoma in a prospective cohort. | De Roos AJ et al. | β | 2013 | β |
| Molecular biomarkers in chronic lymphocytic leukemia. | Malek S | β | 2013 | β |
| Monoclonal B cell lymphocytosis--what does it really mean? | Rawstron AC | β | 2013 | β |
| Parallel processing in immune networks. | Agliari E et al. | β | 2013 | β |
| Pathology consultation on evaluating prognosis in incidental monoclonal lymphocytosis and chronic lymphocytic leukemia. | Siddon AJ et al. | β | 2013 | β |
| Peptides that bind specifically to an antibody from a chronic lymphocytic leukemia clone expressing unmutated immunoglobulin variable region genes. | Liu Y et al. | β | 2013 | β |
| Precursors to lymphoproliferative malignancies. | Goldin LR et al. | β | 2013 | β |
| T-cell clonality is detected in a high frequency among patients with incidental lymphocytosis by PCR assays for TCR gene rearrangements. | Cao F et al. | β | 2013 | β |
| Allogeneic hematopoietic cell transplantation in patients with myelodysplastic syndrome and concurrent lymphoid malignancy. | Zimmerman Z et al. | β | 2012 | β |
| Antibiotic use and risk of non-Hodgkin lymphomas. | Rasmussen ML et al. | β | 2012 | β |
| Case study interpretation--Portland: Case 1. Hairy cell leukemia with CLL-like monoclonal B lymphocytosis. | Tembhare P et al. | β | 2012 | β |
| Cellular origin and pathophysiology of chronic lymphocytic leukemia. | Seifert M et al. | β | 2012 | β |
| Clinical aspects of monoclonal B-cell lymphocytosis. | Mowery YM et al. | β | 2012 | β |
| Common infectious agents and monoclonal B-cell lymphocytosis: a cross-sectional epidemiological study among healthy adults. | Casabonne D et al. | β | 2012 | β |
| Detectable clonal mosaicism from birth to old age and its relationship to cancer. | Laurie CC et al. | β | 2012 | β |
| Early lesions in lymphoid neoplasia: Conclusions based on the Workshop of the XV. Meeting of the European Association of Hematopathology and the Society of Hematopathology, in Uppsala, Sweden. | Fend F et al. | β | 2012 | β |
| Functional dissection of the chromosome 13q14 tumor-suppressor locus using transgenic mouse lines. | Lia M et al. | β | 2012 | β |
| Markers of B-cell activation in relation to risk of non-Hodgkin lymphoma. | De Roos AJ et al. | β | 2012 | β |
| Molecular pathogenesis of chronic lymphocytic leukemia. | Gaidano G et al. | β | 2012 | β |
| Monoclonal B-cell lymphocytosis: a reappraisal of its clinical implications. | Molica S et al. | β | 2012 | β |
| Monoclonal B-cell lymphocytosis is closely related to chronic lymphocytic leukaemia and may be better classified as early-stage CLL. | Kern W et al. | β | 2012 | β |
| Monoclonal B-cell lymphocytosis (MBL) with normal lymphocyte counts is associated with decreased numbers of normal circulating B-cell subsets. | Hauswirth AW et al. | β | 2012 | β |
| Monoclonal B-cell lymphocytosis: right track or red herring? | Ghia P et al. | β | 2012 | β |
| Occupational pesticide exposures and cancer risk: a review. | Alavanja MC et al. | β | 2012 | β |
| Small lymphocytic lymphoma and chronic lymphocytic leukemia: are they the same disease? | Santos FP et al. | β | 2012 | β |
| Survival of patients with clinically identified monoclonal B-cell lymphocytosis (MBL) relative to the age- and sex-matched general population. | Shanafelt TD et al. | β | 2012 | β |
| Technologies supporting analytical cytology: clinical, research and drug discovery applications. | Cecic IK et al. | β | 2012 | β |
| The current lymphoma classification: new concepts and practical applications triumphs and woes. | Bakshi N et al. | β | 2012 | β |
| A matter of debate in chronic lymphocytic leukemia: is the occurrence of autoimmune disorders an indicator of chronic lymphocytic leukemia therapy? | Strati P et al. | β | 2011 | β |
| CLL-like B-lymphocytes are systematically present at very low numbers in peripheral blood of healthy adults. | Almeida J et al. | β | 2011 | β |
| Early steps of follicular lymphoma pathogenesis. | Roulland S et al. | β | 2011 | β |
| General population low-count CLL-like MBL persists over time without clinical progression, although carrying the same cytogenetic abnormalities of CLL. | Fazi C et al. | β | 2011 | β |
| Genome-wide association study identifies a novel susceptibility locus at 6p21.3 among familial CLL. | Slager SL et al. | β | 2011 | β |
| Immunologic aspects of monoclonal B-cell lymphocytosis. | Lanasa MC et al. | β | 2011 | β |
| Immunophenotypic and gene expression analysis of monoclonal B-cell lymphocytosis shows biologic characteristics associated with good prognosis CLL. | Lanasa MC et al. | β | 2011 | β |
| Inflammation, the microenvironment and chronic lymphocytic leukemia. | Caligaris-Cappio F | β | 2011 | β |
| Molecular and flow cytometry characterization during the follow-up of three simultaneous lymphoproliferative disorders: hairy cell leukemia, monoclonal B-cell lymphocytosis, and CD4(++) /CD8(+/- dim) T-large granular lymphocytosis--a case report. | Garrido P et al. | β | 2011 | β |
| Occult B-cell lymphoproliferative disorders. | Rawstron AC | β | 2011 | β |
| Reassessment of small lymphocytic lymphoma in the era of monoclonal B-cell lymphocytosis. | Gibson SE et al. | β | 2011 | β |
| Recent advances in cytometry applications: preclinical, clinical, and cell biology. | Mittag A et al. | β | 2011 | β |
| Self-renewing hematopoietic stem cell is the primary target in pathogenesis of human chronic lymphocytic leukemia. | Kikushige Y et al. | β | 2011 | β |
| Surprise! HSC are aberrant in chronic lymphocytic leukemia. | Alizadeh AA et al. | β | 2011 | β |
| The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications. | Campo E et al. | β | 2011 | β |
| Utility of laboratory tests in B-CLL patients in different clinical stages. | Rusak M et al. | β | 2011 | β |
| A computer simulation for exploring the detection of monoclonal B-cell lymphocytosis by flow cytometry. | Champion PD | β | 2010 | β |
| Advances in understanding benzene health effects and susceptibility. | Smith MT | β | 2010 | β |
| Anticipation in families with chronic lymphocytic leukemia and other lymphoproliferative disorders. | Awan H et al. | β | 2010 | β |
| Biologic and clinical significance of molecular profiling in Chronic Lymphocytic Leukemia. | Butler T et al. | β | 2010 | β |
| CLL-like monoclonal B-cell lymphocytosis: are we all bound to have it? | ScarfΓ² L et al. | β | 2010 | β |
| Commentary: Comparison of current flow cytometry methods for monoclonal B cell lymphocytosis detection. | Nieto WG et al. | β | 2010 | β |
| Common occurrence of monoclonal B-cell lymphocytosis among members of high-risk CLL families. | Goldin LR et al. | β | 2010 | β |
| Different biology and clinical outcome according to the absolute numbers of clonal B-cells in monoclonal B-cell lymphocytosis (MBL). | Rawstron AC et al. | β | 2010 | β |
| Evolution of a precursor. | Caporaso NE et al. | β | 2010 | β |
| Familial Aspects of Chronic Lymphocytic Leukemia, Monoclonal B-Cell Lymphocytosis (MBL), and Related Lymphomas. | Goldin LR et al. | β | 2010 | β |
| Familial chronic lymphocytic leukemia. | Goldin LR et al. | β | 2010 | β |
| Flow cytometry and laser scanning cytometry, a comparison of techniques. | Mach WJ et al. | β | 2010 | β |
| From pathogenesis to treatment of chronic lymphocytic leukaemia. | Zenz T et al. | β | 2010 | β |
| Identical IGHV-D-J gene rearrangement may precede the clinical onset of chronic lymphocytic leukemia by several years. | Frezzato M et al. | β | 2010 | β |
| LEF-1 is a prosurvival factor in chronic lymphocytic leukemia and is expressed in the preleukemic state of monoclonal B-cell lymphocytosis. | Gutierrez A et al. | β | 2010 | β |
| Long-term follow-up of monoclonal B-cell lymphocytosis detected in environmental health studies. | Marti GE et al. | β | 2010 | β |
| Low levels of monoclonal small B cells in the bone marrow of patients with diffuse large B-cell lymphoma of activated B-cell type but not of germinal center B-cell type. | Tierens AM et al. | β | 2010 | β |
| Monoclonal B cell lymphocytosis. | Lanasa MC et al. | β | 2010 | β |
| Monoclonal B cell lymphocytosis: clinical and population perspectives. | Caporaso NE et al. | β | 2010 | β |
| Monoclonal B cell lymphocytosis in hepatitis C virus infected individuals. | Fazi C et al. | β | 2010 | β |
| Monoclonal B-cell lymphocytosis (MBL): biology, natural history and clinical management. | Shanafelt TD et al. | β | 2010 | β |
| New insights into the pathogenesis of chronic lymphocytic leukemia. | Klein U et al. | β | 2010 | β |
| Non-CLL-like monoclonal B-cell lymphocytosis in the general population: prevalence and phenotypic/genetic characteristics. | Nieto WG et al. | β | 2010 | β |
| Passenger mutations as a marker of clonal cell lineages in emerging neoplasia. | Salk JJ et al. | β | 2010 | β |
| Prevalence of monoclonal B-cell lymphocytosis: a systematic review. | Shim YK et al. | β | 2010 | β |
| Second malignancy risks after non-Hodgkin's lymphoma and chronic lymphocytic leukemia: differences by lymphoma subtype. | Morton LM et al. | β | 2010 | β |
| Single-cell analysis reveals oligoclonality among 'low-count' monoclonal B-cell lymphocytosis. | Lanasa MC et al. | β | 2010 | β |
| T-cell lymphoproliferative disorder potentially induced by imatinib in a patient with GIST. | Verbeek M et al. | β | 2010 | β |
| The DLEU2/miR-15a/16-1 cluster controls B cell proliferation and its deletion leads to chronic lymphocytic leukemia. | Klein U et al. | β | 2010 | β |
| Unraveling the interactions between environmental factors and genetic polymorphisms in non-Hodgkin lymphoma risk. | Wang SS et al. | β | 2010 | β |
| Where is the biology of CLL leading us? | Caligaris-Cappio F et al. | β | 2010 | β |
| Commentary on the WHO classification of tumors of lymphoid tissues (2008): indolent B cell lymphomas. | Ott G et al. | β | 2009 | β |
| Epigenetic alterations in a murine model for chronic lymphocytic leukemia. | Chen SS et al. | β | 2009 | β |
| Evidence of serum immunoglobulin abnormalities up to 9.8 years before diagnosis of chronic lymphocytic leukemia: a prospective study. | Tsai HT et al. | β | 2009 | β |
| Genetic and immune-related factors in the pathogenesis of lymphoproliferative and plasma cell malignancies. | Kristinsson SY et al. | β | 2009 | β |
| Genetic lesions in chronic lymphocytic leukemia: clinical implications. | Montserrat E et al. | β | 2009 | β |
| Increased frequency (12%) of circulating chronic lymphocytic leukemia-like B-cell clones in healthy subjects using a highly sensitive multicolor flow cytometry approach. | Nieto WG et al. | β | 2009 | β |
| Intrinsic and extrinsic factors influencing the clinical course of B-cell chronic lymphocytic leukemia: prognostic markers with pathogenetic relevance. | Dal-Bo M et al. | β | 2009 | β |
| Just exactly how common is CLL? | Hamblin TJ | β | 2009 | β |
| Measurement and clinical monitoring of human lymphocyte clonality by massively parallel VDJ pyrosequencing. | Boyd SD et al. | β | 2009 | β |
| Monoclonal B-cell lymphocytosis. | Rawstron AC | β | 2009 | β |
| Monoclonal B-cell lymphocytosis in first-degree relatives of patients with sporadic (non-familial) chronic lymphocytic leukaemia. | Matos DM et al. | β | 2009 | β |
| Primary T-cell lymphoma of the retina and cerebellum: immunophenotypic and gene rearrangement confirmation. | Bhat PV et al. | β | 2009 | β |
| The 2008 WHO classification of lymphomas: implications for clinical practice and translational research. | Jaffe ES | β | 2009 | β |
| The changing definition of CLL. | Marti GE | β | 2009 | β |
| The precursor of chronic lymphocytic leukemia. | Mulligan CS et al. | β | 2009 | β |
| The secret lives of monoclonal B cells. | Vogt RF et al. | β | 2009 | β |